Vitamins Antitrust Settlements: What the Class Actually Recovered

Vitamins antitrust settlement opt-outs sharply reduced the class recovery in the price-fixing case involving Roche, BASF and other vitamin suppliers. The court’s 2001 fee opinion identified an approximately $1.05 billion ceiling before purchasers left the class and approximately $242 million in actual class recovery at that stage. The billion-dollar ceiling was never the amount the remaining buyers recovered.

Why Opt-Outs Changed the Vitamins Class Recovery

Purchasers leaving the class reduced the amount available through the class settlement. The settlement covered buyers purchasing directly from suppliers accused of fixing vitamin prices and dividing sales among themselves. An opt-out leaves the pooled class recovery to pursue its own claim.

When the court approved the settlement in 2000, it estimated a class distribution of approximately $325 million. By the later fee decision, the court was evaluating a smaller recovery for the buyers who remained. It refused to count the original ceiling as money the class actually got when setting fees.

Vitamin Products and Choline Chloride Had Separate Funds

The vitamin-products and choline-chloride settlements had separate funds and different payment mechanics. The fee awards followed that separation. The fee opinion approved $123,188,032 in separately funded fees.

The payment-card settlement also lost funds when buyers opted out, including a $700 million reduction in the court’s account.

The Vitamin Business Behind the Price-Fixing Allegations

The alleged scheme reached ingredients sold into human food, pharmaceuticals and animal feed, including premixes used to enrich food and feed products. The Department of Justice’s criminal information against F. Hoffmann-La Roche describes that business.

The information describes premixes as blends of vitamins and other products, supplied in dry or spray-on applications. That puts the alleged conduct at an ingredient supplier’s sales desk and a food or feed manufacturer’s purchasing desk. The buyer purchased an additive for its products.

The criminal information described a changing group of participants and vitamin products over the charged period. Its allegations included vitamins A and E, riboflavin, other vitamins and beta carotene, as well as premixes.

Price Agreements Had Sales Volumes Behind Them

The Hoffmann-La Roche information alleged coordinated vitamin prices and sales volumes, enforced through customer data and protected premix bids.

For an insider, the connection between a price instruction and a customer-volume exchange can explain more than either document alone.

Premix Bids Had a Winner Chosen in Advance

That allegation gives bid records their importance. A buyer may know which offers arrived and which supplier won. Someone on the supplier’s side may know why a price was set high, why a bid was withheld or who decided that another company should take the contract. Together, those accounts connect the purchase to the alleged agreement behind it.

Why Pricing Records Need Commercial Context

A sales employee may be able to explain the purpose of an exchange that looks ordinary when reduced to a spreadsheet. A purchaser may be able to connect a supplier’s bid to the contract it ultimately received. The commercial meaning of those records is what makes industry knowledge useful.

The settlement figures answer what the class recovered. Those underlying records address why buyers may have been overcharged in the first place.

Whistleblower Rewards for Antitrust Evidence

We assess which whistleblower opportunity fits the conduct you know and the information you hold. The Department of Justice’s Antitrust Division announced a rewards program in 2025 with postal partners. We can assess whether it fits your information about coordinated vitamin prices or premix bids.

For a buyer who also has inside knowledge, both the purchases and the source of that knowledge matter. We assess the conduct, your connection to it and the reporting opportunity together.

How Much of a Settlement Does a Whistleblower Get?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. If you know that coordinated vitamin prices reached government purchasing, that connection is worth discussing with our whistleblower experts. We assess the alleged agreement alongside the government-payment evidence and bring the relevant expertise to the case.

When You Know Who Set the Price

Explain the vitamin-price instruction or customer-volume exchange to our whistleblower experts so we can follow the agreement behind the purchaser claims.